DK549188A - Lymfocythaemmende hla-peptider - Google Patents

Lymfocythaemmende hla-peptider

Info

Publication number
DK549188A
DK549188A DK549188A DK549188A DK549188A DK 549188 A DK549188 A DK 549188A DK 549188 A DK549188 A DK 549188A DK 549188 A DK549188 A DK 549188A DK 549188 A DK549188 A DK 549188A
Authority
DK
Denmark
Prior art keywords
ctl
peptides
hla peptides
alpha
lymphocyte inhibitor
Prior art date
Application number
DK549188A
Other languages
English (en)
Other versions
DK549188D0 (da
Inventor
Alan M Krensky
Peter Parham
Carol Clayberger
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of DK549188D0 publication Critical patent/DK549188D0/da
Publication of DK549188A publication Critical patent/DK549188A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK549188A 1987-01-30 1988-09-30 Lymfocythaemmende hla-peptider DK549188A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US884687A 1987-01-30 1987-01-30
US13854787A 1987-12-24 1987-12-24
PCT/US1988/000245 WO1988005784A1 (en) 1987-01-30 1988-01-27 Lymphocyte inhibition by hla peptides

Publications (2)

Publication Number Publication Date
DK549188D0 DK549188D0 (da) 1988-09-30
DK549188A true DK549188A (da) 1988-11-30

Family

ID=26678694

Family Applications (1)

Application Number Title Priority Date Filing Date
DK549188A DK549188A (da) 1987-01-30 1988-09-30 Lymfocythaemmende hla-peptider

Country Status (7)

Country Link
EP (1) EP0365525B1 (da)
AT (1) ATE126237T1 (da)
AU (1) AU619458B2 (da)
CA (1) CA1339185C (da)
DE (1) DE3854300T2 (da)
DK (1) DK549188A (da)
WO (1) WO1988005784A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7011834B1 (en) 1987-01-30 2006-03-14 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
US5888512A (en) * 1987-01-30 1999-03-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by HLA peptides
US5723128A (en) * 1987-01-30 1998-03-03 The Board Of Trustees Of The Leland Stanford Junior University Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides
JP3015058B2 (ja) * 1989-03-03 2000-02-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 表面レセプター活性のクラスｉｍｈｃ調節
DE4143467C2 (de) * 1991-05-17 1995-02-09 Max Planck Gesellschaft Peptidmotiv und dessen Verwendung
ES2136094T3 (es) * 1991-11-08 1999-11-16 Univ Leland Stanford Junior Peptidos capaces de unirse a las moleculas cd8 sobre los precursores de ctl.
ZA932568B (en) * 1992-04-24 1993-11-12 Baylor College Midecine A Non Production of recombinant human lactoferrin
EP0671926B1 (en) * 1992-08-11 2002-11-13 President And Fellows Of Harvard College Immunomodulatory peptides
DE4238416A1 (de) * 1992-11-13 1994-05-19 Max Planck Gesellschaft Bestimmung von Peptidmotiven auf MHC-Molekülen
EP0684837A1 (en) * 1993-02-17 1995-12-06 Immune Network Research, Ltd. Methods for modifying the t cell repertoire of the immune system
US6162434A (en) * 1995-05-03 2000-12-19 Sangstat Medical Corporation Cytomodulating peptide for inhibiting lymphocyte activity
US5753625A (en) * 1995-05-12 1998-05-19 Sangstat Medical Corporation Treatment for inhibiting the progression of autoimmune disease
US6056952A (en) * 1995-08-30 2000-05-02 The United States Of America As Represented By The Department Of Health And Human Services Selective elimination of T cells that recognize specific preselected targets
US6436903B1 (en) 1996-05-22 2002-08-20 Stanford University (Board Of Trustees Of The Leland Standford Junior University) Immunomodulating compounds comprising d-isomers of amino acids
WO1997044351A1 (en) * 1996-05-24 1997-11-27 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
CN1216900C (zh) 1997-04-11 2005-08-31 桑斯塔特医学有限公司 用于调节免疫系统活性和抑制炎症的细胞调节性亲脂肽
US6696545B1 (en) 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
AU2003210659A1 (en) 2002-01-24 2003-09-02 Sangstat Medical Corporation Combination therapy for treatment of hiv infection
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection

Also Published As

Publication number Publication date
ATE126237T1 (de) 1995-08-15
EP0365525B1 (en) 1995-08-09
EP0365525A1 (en) 1990-05-02
DE3854300D1 (de) 1995-09-14
CA1339185C (en) 1997-07-29
AU619458B2 (en) 1992-01-30
EP0365525A4 (en) 1990-12-12
WO1988005784A1 (en) 1988-08-11
AU1342388A (en) 1988-08-24
DE3854300T2 (de) 1996-01-11
DK549188D0 (da) 1988-09-30

Similar Documents

Publication Publication Date Title
DK549188A (da) Lymfocythaemmende hla-peptider
ES2128362T3 (es) Fragmentos de proteinas de prion.
ES2139012T3 (es) Peptidos de la proteina p53 humana destinados para ser utilizados en composiciones que inducen una reaccion en los linfocitos t humanos, y linfocitos t citotoxicos especificos de la proteina p53 humana.
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
DE69733247D1 (de) Humanisiertes grünes-fluoreszenzprotein und methoden
AU4128089A (en) Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
ZA975851B (en) Hepatocyte grown factor receptor agonists and uses thereof
GR3034964T3 (en) Lymphocyte activity regulation by hla peptides.
ATE113845T1 (de) Monoklonale antikörper gegen glycolipid-antigene und ihre verwendung.
ES2120964T3 (es) Peptidos osteogenicos.
DK0668772T3 (da) Specifik immunsystemmodulering
ATE250625T1 (de) IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
DE69434384D1 (de) Metalkomplexbildner
JPS6456697A (en) Viii factor bonded domain of von willebrand's factor
ES2186717T3 (es) Regulacion de la actividad de los linfocitos t citotoxicos ("ctl") mediante peptidos de la clase i del mhc.
ES2103854T3 (es) Peptidos con actividad organo protectiva, procedimiento para la preparacion de los mismos y su utilizacion en la terapia.
DE69330352T2 (de) Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut
ATE225806T1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
DK0625157T3 (da) Blodplade-GPIIIaP1A1- og -P1A2-epitoper og fremstilling og anvendelse deraf
AU7423391A (en) Dna constructs for the expression of proteins in the mammary gland of transgenetic mammals
DK0463053T3 (da) Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
DE3751834D1 (de) Selbstantigen der primären lebercirrhose
GR3005231T3 (da)
IT1262898B (it) Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment